Astex Pharmaceuticals to Announce 2013 Second Quarter Financial Results on August 1st
July 29, 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 29, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Announces First Data Showing Early Combination Treatment of HSP90 Inhibitor AT13387 With Targeted Agents Delays Emergence of Resistance in Preclinical Models
July 22, 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 22, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in-Class Oral Hypomethylator
July 08, 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 8, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals to Present at JMP Securities Healthcare Conference
July 03, 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 3, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Data at the Upcoming European Cancer Congress (ECCO-ESMO-ESTRO)
June 20, 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., June 20, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Announces Presentation of Updated Results of SGI-110-01 Study in Patients With Intermediate or High Risk Relapsed or Refractory Myelodysplastic Syndromes at the European Hematology Association
June 14, 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., June 14, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals to Present at Jefferies Global Healthcare Conference
May 29, 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., May 29, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals to Present at UBS Global Healthcare Conference
May 14, 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., May 14, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Reports 2013 First Quarter Financial Results
April 29, 2013 16:00 ET
|
Astex Pharmaceuticals, Inc.
Data reported at AACR on several preclinical and clinical programs
Ends quarter with $137 million in cash & marketable securities
First quarter royalty revenue increases 7.3% to $22.1...
Astex Pharmaceuticals to Present at Needham Healthcare Conference
April 23, 2013 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., April 23, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...